Protara Therapeutics, Inc.
TARA
$3.40
-$0.12-3.41%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 159.67% | 10.08% | 11.47% | -36.24% | -22.27% |
Total Receivables | -- | -- | -- | -95.32% | -50.21% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 4.39% | 60.96% | 25.15% | -1.14% | 49.66% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -53.11% | -9.36% | -41.94% | -75.82% | 186.49% |
Total Current Assets | 150.57% | 9.34% | 9.43% | -38.79% | -20.25% |
|
|||||
Total Current Assets | 150.57% | 9.34% | 9.43% | -38.79% | -20.25% |
Net Property, Plant & Equipment | -19.48% | -19.30% | -17.89% | -17.63% | -16.63% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 8.89% | -8.17% | -4.03% | 199.77% | 165.59% |
Total Assets | 129.82% | 6.36% | 6.84% | -35.97% | -30.31% |
|
|||||
Total Accounts Payable | 81.96% | -8.35% | -25.22% | -76.18% | 53.47% |
Total Accrued Expenses | 97.95% | 59.39% | 51.48% | 152.79% | -15.60% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 14.34% | 11.70% | 9.06% | 7.18% | 7.20% |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 78.26% | 27.56% | 14.52% | -14.18% | 7.13% |
|
|||||
Total Current Liabilities | 78.26% | 27.56% | 14.52% | -14.18% | 7.13% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -25.09% | -22.78% | -20.77% | -19.13% | -17.98% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 34.68% | 6.85% | -3.22% | -16.40% | -5.12% |
|
|||||
Common Stock & APIC | 53.35% | 17.47% | 17.75% | 2.13% | 2.28% |
Retained Earnings | -22.26% | -22.11% | -22.57% | -25.13% | -25.27% |
Treasury Stock & Other | 106.45% | 117.58% | -- | 99.79% | 95.49% |
Total Common Equity | 144.63% | 6.28% | 8.01% | -38.37% | -33.07% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 144.63% | 6.28% | 8.01% | -38.37% | -33.07% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 144.63% | 6.28% | 8.01% | -38.37% | -33.07% |
|